Update on pituitary surgery

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 4, 2012, Pages 1073-1081

  Swearingen, Brooke ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACROMEGALY; COMPUTER ASSISTED SURGERY; COST BENEFIT ANALYSIS; CUSHING HALSTEAD SUBLABIAL APPROACH; DECOMPRESSION SURGERY; ENDOSCOPIC SURGERY; EXTENDED TRANSSPHENOIDAL APPROACH; FLUOROSCOPY; HIRSCH ENDONASAL TECHNIQUE; HUMAN; HYPOPHYSIS TUMOR; INTERMETHOD COMPARISON; MEDICAL LITERATURE; MICROSCOPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPERATION DURATION; OPTIC CHIASM; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROLACTINOMA; REVIEW; SAFETY; SURGICAL APPROACH; SURGICAL TECHNIQUE; TRANSSPHENOIDAL SURGERY;

COST-BENEFIT ANALYSIS; ENDOSCOPY; HEALTH CARE COSTS; HUMANS; INTRAOPERATIVE PERIOD; MAGNETIC RESONANCE IMAGING; MICROSURGERY; PITUITARY DISEASES; PITUITARY GLAND; PITUITARY NEOPLASMS;

EID: 84859542868     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-3237     Document Type: Review

References (72)

1. Barker 2nd FG, Klibanski A, Swearingen B 2003 Transsphenoidal surgery for pituitary tumors in the United States 1996-2000: mortality, morbidity, and effects of hospital and surgeon volume. J Clin Endocrinol Metab 88:4709-4719 (Pubitemid 37357516)
2. Valassi E, Biller BM, Klibanski A, Swearingen B 2010 Clinical features of nonpituitary sellar lesions in a large surgical series. Clin Endocrinol (Oxf) 73:798-807
3. Famini P, Maya MM, Melmed S 2011 Pituitary magnetic resonance imaging for sellar and parasellar masses: ten-year experience in 2598 patients. J Clin Endocrinol Metab 96:1633-1641
4. Kanter AS, Dumont AS, Asthagiri AR, Oskouian RJ, Jane Jr JA, Laws Jr ER 2005 The transsphenoidal approach. A historical perspective. Neurosurg Focus 18:e6
5. Steinmeier R, Fahlbusch R, Ganslandt O, Nimsky C, Buchfelder M, Kaus M, Heigl T, Lenz G, Kuth R, Huk W 1998 Intra-operative magnetic resonance imaging with the magnetom open scanner: concepts, neurosurgical indications, and procedures: a preliminary report. Neurosurgery 43:739-747; discussion 747-748
6. Martin CH, Schwartz R, Jolesz F, Black PM 1999 Transsphenoidal resection of pituitary adenomas in an intra-operative MRI unit. Pituitary 2:155-162
7. Bohinski RJ, Warnick RE, Gaskill-Shipley MF, Zuccarello M, van Loveren HR, Kormos DW, Tew Jr JM 2001 Intra-operative magnetic resonance imaging to determine the extent of resection of pituitary macroadenomas during transsphenoidal microsurgery. Neurosurgery 49:1133-1143; discussion 1143-1144
8. Fahlbusch R, Keller B, Ganslandt O, Kreutzer J, Nimsky C 2005 Trans-sphenoidal surgery in acromegaly investigated by intra-operative high-field magnetic resonance imaging. Eur J Endocrinol 153:239-248
9. Nimsky C, von Keller B, Ganslandt O, Fahlbusch R 2006 Intra-operative high-field magnetic resonance imaging in transsphenoidal surgery of hormonally inactive pituitary macroadenomas. Neurosurgery 59:105-114
10. Gerlach R, du Mesnil de Rochemont R, Gasser T, Marquardt G, Reusch J, Imoehl L, Seifert V 2008 Feasibility of Polestar N20, an ultra-low-field intra-operative magnetic resonance imaging system control of pituitary macroadenomas: lessons learned from the first 40 cases. Neurosurgery 63:272-284; discussion 284-285
11. Wu JS, Shou XF, Yao CJ, Wang YF, Zhuang DX, Mao Y, Li SQ, Zhou LF 2009 Transsphenoidal pituitary macroadenomas resection guided by PoleStar N20 low field intra-operative magnetic resonance imaging: comparison with early postoperative high-field magnetic resonance imaging. Neurosurgery 65:63-70; discussion 70-71
12. Bellut D, Hlavica M, Schmid C, Bernays RL 2010 Intra-operative magnetic resonance imaging-assisted transsphenoidal pituitary surgery in patients with acromegaly. Neurosurg Focus 29:E9
13. Vitaz TW, Inkabi KE, Carrubba CJ 2011 Intra-operative MRI for transsphenoidal procedures: short-term outcome for 100 consecutive cases. Clin Neurol Neurosurg 113:731-735
14. Berkmann S, Fandino J, Zosso S, Killer HE, Remonda L, Landolt H 2011 Intra-operative magnetic resonance imaging and early prognosis for vision after transsphenoidal surgery for sellar lesions. J Neurosurg 115:518-527
15. Netuka D, Masopust V, Belšán T, Kramáø F, Beneš V 2011 One year experience with 3.0 T intra-operative MRI in pituitary surgery. Acta Neurochir Suppl 109:157-159
16. Ramm-Pettersen J, Berg-Johnsen J, Hol PK, Roy S, Bollerslev J, Schreiner T, Helseth E 2011 Intra-operative MRI facilitates tumor resection during trans-sphenoidal surgery for pituitary adenomas. Acta Neurochir (Wien) 153:1367-1373
17. Jankowski R, Auque J, Simon C, Marchal JC, Hepner H, Wayoff M 1992 Endoscopic pituitary tumor surgery. Laryngoscope 102:198-202
18. Jho HD, Alfieri A 2001 Endoscopic endonasal pituitary surgery: evolution of surgical technique and equipment in 150 operations. Minim Invasive Neurosurg 44:1-12 (Pubitemid 32435766)
19. Atkinson JL, Young Jr WF, Meyer FB, Davis DH, Nippoldt TB, Erickson D, Vella A, Natt N, Abboud CF, Carpenter PC 2008 Sublabial transseptal vs transnasal combined endoscopic microsurgery in patients with Cushing disease and MRI-depicted microadenomas. Mayo Clin Proc 83:550-553 (Pubitemid 351717002)
20. Tabaee A, Anand VK, Barrón Y, Hiltzik DH, Brown SM, Kacker A, Mazumdar M, Schwartz TH 2009 Endoscopic pituitary surgery: a systematic review and meta-analysis. J Neurosurg 111:545-554
21. Dorward NL 2010 Endocrine outcomes in endoscopic pituitary surgery, a literature review. Acta Neurochir (Wien) 152:1275-1279
22. Kabil MS, Eby JB, Shahinian HK 2005 Fully endoscopic endonasal vs. transseptal transsphenoidal pituitary surgery. Minim Invasive Neurosurg 48:348-354 (Pubitemid 43219011)
23. Ciric I, Zhao JC, Du H, Findling JW, Molitch ME, Weiss RE, Refetoff S, Kerr WD, Meyer J 2012 Transsphenoidal surgery for Cushing's disease: experience with 136 patients. Neurosurgery 70:70-81
24. Honegger J, Schmalisch K, Beuchlein F, Kaufmann S, Naegele T, Psaras T 25 October 2011 Contemporary microsurgical concept for the treatment of Cushing's disease: endocrine outcome in 83 consecutive patients. Clin Endocrinol (Oxf) doi: 10.1111/j.1365-2265.2011.04268.x
25. Prevedello DM, Pouratian N, Sherman J, Jane Jr JA, Vance ML, Lopes MB, Laws Jr ER 2008 Management of Cushing's disease: outcome in microadenoma detected on pituitary magnetic resonance imaging. J Neurosurg 109:751-759
26. Oldfield EH 2010 Unresolved issues: radiosurgery versus radiation therapy; medical suppression of growth hormone production during radiosurgery; and endoscopic versus microscopic surgery. Neurosurg Focus 29:E16
27. Jho HD 2001 Endoscopic transsphenoidal surgery. J Neurooncol 54:187-195
28. Cappabianca P, Cavallo LM, Colao A, de Divitiis E 2002 Surgical complications associated with the endoscopic endonasal transsphenoidal approach to pituitary adenomas. J Neurosurg 97:293-298 (Pubitemid 34827328)
29. Dehdashti AR, Ganna A, Karabatsou K, Gentili F 2008 Pure endoscopic endonasal approach for pituitary adenomas: early surgical results in 200 patients and comparison with previous microsurgical series. Neurosurgery 62:1006-1015; discussion 1015-1017
30. D'Haens J, Van Rompaey K, Stadnik T, Haentjens P, Poppe K, Velkeniers B 2009 Fully endoscopic transsphenoidal surgery for functioning pituitary adenomas: a retrospective comparison with traditional microsurgery in the same institution. Surg Neurol 72:336-340
31. Yano S, Kawano T, Kudo M, Makino K, Nakamura H, Kai Y, Morioka M, Kuratsu J 2009 Endoscopic endonasal transsphenoidal approach through the bilateral nostrils for pituitary adenomas. Neurol Med Chir (Tokyo) 49:1-7
32. Campbell PG, Kenning E, Andrews DW, Yadla S, Rosen M, Evans JJ 2010 Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas. Neurosurg Focus 29:E5
33. Hofstetter CP, Mannaa RH, Mubita L, Anand VK, Kennedy JW, Dehdashti AR, Schwartz TH 2010 Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas. Neurosurg Focus 29:E6
34. Gondim JA, Schops M, de Almeida JP, de Albuquerque LA, Gomes E, Ferraz T, Barroso FA 2010 Endoscopic endonasal transsphenoidal surgery: surgical results of 228 pituitary adenomas treated in a pituitary center. Pituitary 13:68-77
35. Jane Jr JA, Starke RM, Elzoghby MA, Reames DL, Payne SC, Thorner MO, Marshall JC, Laws Jr ER, Vance ML 2011 Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications and predictors of outcome. J Clin Endocrinol Metab 96:2732-2740
36. Wagenmakers MA, Netea-Maier RT, van Lindert EJ, Pieters GF, Grotenhuis AJ, Hermus AR 2011 Results of endoscopic transsphenoidal pituitary surgery in 40 patients with a growth hormone-secreting macroadenoma. Acta Neurochir (Wien) 153:1391-1399
37. Valassi E, Klibanski A, Biller BM 2010 Clinical review: potential cardiac valve effects of dopamine agonists in hyperprolactinemia. J Clin Endocrinol Metab 95:1025-1033
38. Kreutzer J, Buslei R, Wallaschofski H, Hofmann B, Nimsky C, Fahlbusch R, Buchfelder M 2008 Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients. Eur J Endocrinol 158:11-18 (Pubitemid 351211035)
39. Kharlip J, Salvatori R, Yenokyan G, Wand GS 2009 Recurrence of hyperprolactinemia after withdrawal of long-term cabergoline therapy. J Clin Endocrinol Metab 94:2428-2436
40. Helal MZ 1995 Combined micro-endoscopic transsphenoid excisions of pituitary macroadenoma. Eur Arch Otorhinolaryngol 252:186-189
41. Fatemi N, Dusick JR, de Paiva Neto MA, Kelly DF 2008 The endonasal microscopic approach for pituitary adenomas and other parasellar tumors: a 10-year experience. Neurosurgery 63(4 Suppl 2):244-256
42. Theodosopoulos PV, Leach J, Kerr RG, Zimmer LA, Denny AM, Guthikonda B, Froelich S, Tew JM 2010 Maximizing the extent of tumor resection during transphenoidal surgery for pituitary macroadenomas: can endoscopy replace intra-operative magnetic resonance imaging? J Neurosurg 112:736-743
43. O'Malley Jr BW, Grady MS, Gabel BC, Cohen MA, Heuer GG, Pisapia J, Bohman LE, Leibowitz JM 2008 Comparison of endoscopic and microscopic removal of pituitary adenomas: single-surgeon experience and the learning curve. Neurosurg Focus 25:E10
44. Laws ER, Kanter AS, Jane Jr JA, Dumont AS 2005 Extended transsphenoidal approach. J Neurosurg 102:825-828 (Pubitemid 43194000)
45. Gardner PA, Kassam AB, Snyderman CH, Carrau RL, Mintz AH, Grahovac S, Stefko S 2008 Outcomes following endoscopic, expanded endonasal resection of suprasellar craniopharyngiomas: a case series. J Neurosurg 109:6-16 (Pubitemid 351930516)
46. Zhao B, Wei YK, Li GL, Li YN, Yao Y, Kang J, Ma WB, Yang Y, Wang RZ 2010 Extended transsphenoidal approach for pituitary adenomas invading the anterior cranial base, cavernous sinus and clivus: a single center experience with 126 consecutive cases. J Neurosurg 112:108-117
47. Cappabianca P, Cavallo LM, Esposito F, De Divitiis O, Messina A, De Divitiis E 2008 Extended endoscopic endonasal approach to the midline skull base: the evolving role of transsphenoidal surgery. Adv Tech Stand Neurosurg 33:151-199
48. Frank G, Pasquini E, Doglietto F, Mazzatenta D, Sciarretta V, Farneti G, Calbucci F 2006 The endoscopic extended endonasal transsphenoidal approach for craniopharyngiomas. Neurosurgery 59:ONS75-ONS83
49. Tabaee A, Anand VK, Fraser JF, Brown SM, Singh A, Schwartz TH 2009 Three-dimensional endoscopic pituitary surgery. Neurosurgery 64:288-293; discussion 294-295
50. Watson JC, Shawker TH, Nieman LK, DeVroom HL, Doppman JL, Oldfield EH 1998 Localization of pituitary adenomas by using intraoperative ultrasound in patients with Cushing's disease and no demonstrable pituitary tumor on magnetic resonance imaging. J Neurosurg 89:927-932 (Pubitemid 28544045)
51. Knappe UJ, Engelbach M, Konz K, Lakomek HJ, Saeger W, Schönmayr R, Mann WA 2011 Ultrasound-assisted microsurgery for Cushing's disease. Exp Clin Endocrinol Diabetes 119:191-200
52. Dusick JR, Esposito F, Malkasian D, Kelly DF 2007 Avoidance of carotid artery injuries in transsphenoidal surgery with the Doppler probe and micro-hook blades. Neurosurgery 60(4 Suppl 2):322-328; discussion 328-329
53. Eljamel MS, Leese G, Moseley H 2009 Intra-operative optical identification of pituitary adenomas. J Neurooncol 92:417-421
54. Ludecke DK, Abe T 2006 Transsphenoidal microsurgery for newly diagnosed acromegaly: a personal view after more than 1000 operations. Neuroendocrinology 83:230-239 (Pubitemid 44578877)
55. Graham KE, Samuels MH, Raff H, Barnwell SL, Cook DM 1997 Intra-operative adrenocorticotrophin levels during transsphenoidal surgery for Cushing's disease do not predict cure. J Clin Endocrinol Metab 82:1776-1779 (Pubitemid 127495185)
56. Cowan Jr JA, Dimick JB, Thompson BG, Stanley JC, Upchurch Jr GR 2002 Surgeon volume as an indicator of outcomes after carotid endarterectomy: an effect independent of specialty practice and hospital volume. J Am Coll Surg 195:814-821 (Pubitemid 35470891)
57. Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL 2003 Surgeon volume and operative mortality in the United States. N Engl J Med 349:2117-2127 (Pubitemid 37464537)
58. Gittoes NJ, Sheppard MC, Johnson AP, Stewart PM 1999 Outcome of surgery for acromegaly-the experience of a dedicated pituitary surgeon. QJM 92:741-745
59. Bates PR, Carson MN, Trainer PJ, Wass JA 2008 Wide variation in surgical outcomes for acromegaly in the UK. Clin Endocrinol (Oxf) 68:136-142 (Pubitemid 350243493)
60. Ciric I, Ragin A, Baumgartner C, Pierce D 1997 Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience. Neurosurgery 40:225-236; discussion 236-237
61. Patil CG, Lad SP, Harsh GR, Laws Jr ER, Boakye M 2007 National trends, complications, and outcomes following transsphenoidal surgery for Cushing's disease from 1993 to 2002. Neurosurg Focus 23:E7
62. Shahlaie K, McLaughlin N, Kassam AB, Kelly DF 2010 The role of outcomes data for assessing the expertise of a pituitary surgeon. Curr Opin Endocrinol Diabetes Obes 17:369-376
63. Jane Jr JA, Sulton LD, Laws Jr ER 2005 Surgery for primary brain tumors at United States academic training centers: results from the Residency Review Committee for neurological surgery. J Neurosurg 103:789-793 (Pubitemid 43194571)
64. Biermasz NR, Roelfsema F, Pereira AM, Romijn JA 2009 Cost-effectiveness of lanreotide Autogel in treatment algorithms of acromegaly. Expert Rev Pharmacoecon Outcomes Res 9:223-234
65. Ben-Shlomo A, Sheppard MC, Stephens JM, Pulgar S, Melmed S 2011 Clinical, quality of life, and economic value of acromegaly disease control. Pituitary 14:284-294
66. Didoni G, Grottol S, Gasco V, Battistini M, Ferone D, Giusti M, Ragazzoni F, Ruffo P, Ghigo E, Minuto F 2004 Cost-of-illness study in acromegalic patients in Italy. J Endocrinol Invest 27:1034-1039
67. Luque-Ramírez M, Paramo C, Varela da Costa C, García-Mayor RV 2007 Cost of management of invasive growth hormone-secreting macroadenoma. J Endocrinol Invest 30:541-545 (Pubitemid 47577805)
68. Swearingen B, Wu N, Chen SY, Pulgar S, Biller BM 2011 Health care resource use and costs among patients with Cushing disease. Endocr Pract 17:681-690
69. Barker 2nd FG, Curry Jr WT, Carter BS 2005 Surgery for primary supratentorial brain tumors in the United States, 1988 to 2000: the effect of provider caseload and centralization of care. Neuro Oncol 7:49-63 (Pubitemid 40310193)
70. Biller BM, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, Buchfelder M, Colao A, Hermus AR, Hofland LJ, Klibanski A, Lacroix A, Lindsay JR, Newell-Price J, Nieman LK, Petersenn S, Sonino N, Stalla GK, Swearingen B, Vance ML, Wass JA, Boscaro M 2008 Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 93:2454-2462 (Pubitemid 352008503)
71. Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF, Trainer P, Ghigo E, Ho K, Melmed S 2010 A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95:3141-3148
72. Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, Wass JA 2011 Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:273-288